Protein & Cell (Jan 2016)

Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer

  • Haiyang Zhang,
  • Jingjing Duan,
  • Yanjun Qu,
  • Ting Deng,
  • Rui Liu,
  • Le Zhang,
  • Ming Bai,
  • Jialu Li,
  • Tao Ning,
  • Shaohua Ge,
  • Xia Wang,
  • Zhenzhen Wang,
  • Qian Fan,
  • Hongli Li,
  • Guoguang Ying,
  • Dingzhi Huang,
  • Yi Ba

DOI
https://doi.org/10.1007/s13238-015-0234-5
Journal volume & issue
Vol. 7, no. 2
pp. 141 – 151

Abstract

Read online

ABSTRACT Gastric cancer is one of the most common malignancies worldwide; however, the molecular mechanism in tumorigenesis still needs exploration. BCL2L11 belongs to the BCL-2 family, and acts as a central regulator of the intrinsic apoptotic cascade and mediates cell apoptosis. Although miRNAs have been reported to be involved in each stage of cancer development, the role of miR-24 in GC has not been reported yet. In the present study, miR-24 was found to be up-regulated while the expression of BCL2L11 was inhibited in tumor tissues of GC. Studies from both in vitro and in vivo shown that miR-24 regulates BCL2L11 expression by directly binding with 3′UTR of mRNA, thus promoting cell growth, migration while inhibiting cell apoptosis. Therefore, miR-24 is a novel onco-miRNA that can be potential drug targets for future clinical use.

Keywords